3,5-diiodothyronine has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgartner, A; Brödel, O; Eravci, M; Finke, R; Gräf, KJ; Hiedra, L; Hoell, T; Meinhold, H; Pinna, G; Prengel, H; Stoltenburg-Didinger, G; Thoma, R | 1 |
1 other study(ies) available for 3,5-diiodothyronine and Astrocytoma, Grade IV
Article | Year |
---|---|
Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors.
Topics: Astrocytoma; Brain Injuries; Brain Neoplasms; Craniocerebral Trauma; Diiodothyronines; Glioblastoma; Humans; Liver Diseases; Radioimmunoassay; Reference Values; Sensitivity and Specificity; Sepsis; Thyroxine; Triiodothyronine | 1997 |